Areas Of Interest
- Cardiovascular Disease, Obesity and the use of NOACs
- Stroke prevention with NOACs
- Dual pathway inhibition antithrombotic therapy to reduce major adverse events in patients with CAD and/or PAD
- Identification and management of high risk medically ill patients of thromboprophylaxis during hospitalization and following discharge
Certificate Of Separation
Please click here to view the certificate of separation.
For general questions please email to [email protected].